{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T01:18:44Z","timestamp":1775524724485,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.mcna.2025.03.005","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T07:13:50Z","timestamp":1747034030000},"page":"943-956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Perioperative Management of Oral Anticoagulation in Patients with Venous Thromboembolism"],"prefix":"10.1016","volume":"109","author":[{"given":"John R.","family":"Sherwood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Austin","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiba","family":"Al Jammala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Kaatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mcna.2025.03.005_bib2","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","article-title":"Perioperative management of antithrombotic therapy: an American College of chest Physicians clinical practice guideline","volume":"162","author":"Douketis","year":"2022","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.mcna.2025.03.005_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2021.1693","article-title":"National trends in use of and spending on oral anticoagulants among US medicare beneficiaries from 2011 to 2019","volume":"2","author":"Troy","year":"2021","journal-title":"JAMA Health Forum"},{"issue":"22","key":"10.1016\/j.mcna.2025.03.005_bib4","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMra1206531","article-title":"Management of antithrombotic therapy in patients undergoing invasive procedures","volume":"368","author":"Baron","year":"2013","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.mcna.2025.03.005_bib5","doi-asserted-by":"crossref","first-page":"5044","DOI":"10.1182\/blood-2011-02-329979","article-title":"Perioperative management of patients who are receiving warfarin therapy: an evidence-based and practical approach","volume":"117","author":"Douketis","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.mcna.2025.03.005_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.mcna.2025.03.005_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"issue":"21","key":"10.1016\/j.mcna.2025.03.005_bib8","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.mcna.2025.03.005_bib9","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/CIRCULATIONAHA.111.060061","article-title":"Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation","volume":"126","author":"Lane","year":"2012","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.mcna.2025.03.005_bib10","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation","volume":"373","author":"Douketis","year":"2015","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.mcna.2025.03.005_bib11","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jacc.2016.11.024","article-title":"2017 acc expert consensus decision pathway for periprocedural management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the American College of cardiology clinical expert consensus document task force","volume":"69","author":"Doherty","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.mcna.2025.03.005_bib12","doi-asserted-by":"crossref","first-page":"e1159","DOI":"10.1161\/CIR.0000000000000503","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of cardiology\/American heart association task force on clinical practice guidelines","volume":"135","author":"Nishimura","year":"2017","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.mcna.2025.03.005_bib13","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/jth.13305","article-title":"Periprocedural management of patients receiving a vitamin K antagonist or a direct oral anticoagulant requiring an elective procedure or surgery","volume":"14","author":"Spyropoulos","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.mcna.2025.03.005_bib14","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant","volume":"179","author":"Douketis","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"7","key":"10.1016\/j.mcna.2025.03.005_bib15","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1080\/09546634.2022.2097161","article-title":"Perioperative anticoagulation recommendations for cutaneous oncologic surgery: a review of the literature","volume":"33","author":"Shah","year":"2022","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"10.1016\/j.mcna.2025.03.005_bib16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/ijd.16916","article-title":"Direct oral anticoagulants in skin surgery: a systematic review of their complications and recommendations for perioperative management","volume":"63","author":"Ireland","year":"2024","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.mcna.2025.03.005_bib17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.thromres.2009.01.007","article-title":"Safety of continuing warfarin therapy during cataract surgery: a systematic review and meta-analysis","volume":"124","author":"Jamula","year":"2009","journal-title":"Thromb Res"},{"issue":"10","key":"10.1016\/j.mcna.2025.03.005_bib18","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.mcna.2025.03.005_bib19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s10792-024-02944-x","article-title":"Effect of direct oral anticoagulants on bleeding during and after cataract surgery","volume":"44","author":"Maytal","year":"2024","journal-title":"Int Ophthalmol"},{"issue":"11","key":"10.1016\/j.mcna.2025.03.005_bib20","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/s41433-019-0527-7","article-title":"Novel oral anticoagulants in cataract surgery-moving towards a national consensus regarding perioperative continuation","volume":"33","author":"Patel","year":"2019","journal-title":"Eye (Lond)"},{"issue":"3","key":"10.1016\/j.mcna.2025.03.005_bib21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10792-018-0862-x","article-title":"Phacoemulsification cataract surgery in patients receiving novel oral anticoagulant medications","volume":"39","author":"Cheung","year":"2019","journal-title":"Int Ophthalmol"},{"issue":"12","key":"10.1016\/j.mcna.2025.03.005_bib23","first-page":"1183","article-title":"Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis","volume":"126","author":"Nematullah","year":"2009","journal-title":"Tex Dent J"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2025.03.005_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/odi.13086","article-title":"World workshop on oral medicine VII: direct anticoagulant agents management for invasive oral procedures: a systematic review and meta-analysis","volume":"25","author":"Manfredi","year":"2019","journal-title":"Oral Dis"},{"issue":"10","key":"10.1016\/j.mcna.2025.03.005_bib25","doi-asserted-by":"crossref","first-page":"e604","DOI":"10.1161\/CIR.0000000000000477","article-title":"Management of patients on non-vitamin K antagonist oral anticoagulants in the acute care and periprocedural setting: a scientific statement from the American heart association","volume":"135","author":"Raval","year":"2017","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.mcna.2025.03.005_bib26","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/gutjnl-2015-311110","article-title":"Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines","volume":"65","author":"Veitch","year":"2016","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.mcna.2025.03.005_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gie.2015.09.035","article-title":"The management of antithrombotic agents for patients undergoing GI endoscopy","volume":"83","author":"Committee","year":"2016","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"10.1016\/j.mcna.2025.03.005_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/gutjnl-2017-315131","article-title":"Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines","volume":"67","author":"Chan","year":"2018","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.mcna.2025.03.005_bib29","doi-asserted-by":"crossref","first-page":"542","DOI":"10.14309\/ajg.0000000000001627","article-title":"American College of Gastroenterology-Canadian association of Gastroenterology clinical practice guideline: management of anticoagulants and antiplatelets during acute gastrointestinal bleeding and the periendoscopic period","volume":"117","author":"Abraham","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.mcna.2025.03.005_bib30","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/AAP.0000000000000763","article-title":"Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American society of regional anesthesia and pain medicine evidence-based guidelines (fourth edition)","volume":"43","author":"Horlocker","year":"2018","journal-title":"Reg Anesth Pain Med"},{"issue":"3","key":"10.1016\/j.mcna.2025.03.005_bib31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.cll.2024.04.014","article-title":"Assessing direct oral anticoagulants in the clinical laboratory","volume":"44","author":"Gosselin","year":"2024","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.mcna.2025.03.005_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtha.2024.07.009","article-title":"Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH","author":"Levy","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.mcna.2025.03.005_bib33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal \u2013 full cohort analysis","volume":"377","author":"Pollack","year":"2017","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.mcna.2025.03.005_bib34","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1814051","article-title":"Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors","volume":"380","author":"Connolly","year":"2019","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.mcna.2025.03.005_bib35","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1056\/NEJMoa2313040","article-title":"Andexanet for factor Xa inhibitor-associated acute intracerebral hemorrhage","volume":"390","author":"Connolly","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.mcna.2025.03.005_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100107","article-title":"Four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-associated bleeding: a meta-analysis of fixed versus variable dosing","volume":"7","author":"Chiasakul","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"2","key":"10.1016\/j.mcna.2025.03.005_bib37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11239-007-0022-z","article-title":"Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin","volume":"24","author":"Woods","year":"2007","journal-title":"J Thromb Thrombolysis"},{"issue":"6","key":"10.1016\/j.mcna.2025.03.005_bib38","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.amjmed.2019.01.004","article-title":"Periprocedural bridging in patients with venous thromboembolism: a systematic review","volume":"132","author":"Baumgartner","year":"2019","journal-title":"Am J Med"},{"issue":"8","key":"10.1016\/j.mcna.2025.03.005_bib39","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/jth.12613","article-title":"Loading dose vs. maintenance dose of warfarin for reinitiation after invasive procedures: a randomized trial","volume":"12","author":"Schulman","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.mcna.2025.03.005_bib40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11239-017-1553-6","article-title":"A randomized trial of restarting warfarin at maintenance versus loading doses following an elective procedure","volume":"44","author":"Bungard","year":"2017","journal-title":"J Thromb Thrombolysis"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712525000525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712525000525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:41:24Z","timestamp":1762213284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712525000525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0025712525000525"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2025.03.005","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative Management of Oral Anticoagulation in Patients with Venous Thromboembolism","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2025.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}